Valuation: AstraZeneca PLC

Capitalization 313B 267B 246B 232B 432B 29,282B 443B 2,885B 1,134B 13,984B 1,174B 1,149B 49,953B P/E ratio 2026 *
25.4x
P/E ratio 2027 * 22.4x
Enterprise value 332B 283B 261B 247B 458B 31,057B 470B 3,060B 1,203B 14,832B 1,245B 1,218B 52,980B EV / Sales 2026 *
5.25x
EV / Sales 2027 * 4.83x
Free-Float
96.62%
Yield 2026 *
1.65%
Yield 2027 * 1.75%
1 day-0.27%
1 week+0.11%
Current month+1.93%
1 month+4.25%
3 months+4.38%
6 months+17.55%
Current year+8.59%
1 week 14,922
Extreme 14922
15,450
1 month 13,478
Extreme 13478
15,450
Current year 13,268
Extreme 13268
15,732
1 year 9,651
Extreme 9651
15,732
3 years 9,461
Extreme 9461
15,732
5 years 7,237
Extreme 7237
15,732
10 years 3,680
Extreme 3680
15,732
Manager TitleAgeSince
Chief Executive Officer 65 01/10/2012
Director of Finance/CFO 52 01/08/2021
Chief Tech/Sci/R&D Officer - 01/08/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 65 01/10/2012
Director/Board Member 65 27/04/2017
Change 5d. change 1-year change 3-years change Capi.($)
-0.29%+0.11%+45.10%+25.92% 313B
-1.06%+0.27%+26.92%+147.78% 832B
-0.21%-1.25%+56.83%+43.25% 573B
-0.71%-0.11%+17.95%+26.91% 365B
+0.35%-0.75%+29.45%+14.12% 322B
-1.05%-0.58%+51.74%+3.95% 297B
-0.16%+0.63%+35.86%+37.86% 292B
-0.34%+2.12%+22.32%+39.13% 189B
+0.03%-0.78%+34.16%+66.96% 173B
+3.66%+5.00%-43.36%-56.87% 166B
Average +0.13%-0.52%+27.70%+34.90% 352.05B
Weighted average by Cap. -0.03%-0.60%+32.34%+54.52%

Financials

2026 *2027 *
Net sales 63.18B 53.98B 49.77B 46.97B 87.28B 5,916B 89.49B 583B 229B 2,825B 237B 232B 10,093B 67.07B 57.3B 52.83B 49.86B 92.65B 6,281B 95B 619B 243B 2,999B 252B 246B 10,714B
Net income 12.5B 10.68B 9.85B 9.29B 17.27B 1,170B 17.7B 115B 45.34B 559B 46.91B 45.92B 1,997B 14.11B 12.06B 11.12B 10.49B 19.49B 1,321B 19.99B 130B 51.19B 631B 52.96B 51.84B 2,254B
Net Debt 18.95B 16.19B 14.93B 14.09B 26.18B 1,774B 26.84B 175B 68.74B 847B 71.12B 69.61B 3,027B 11.01B 9.41B 8.67B 8.18B 15.21B 1,031B 15.6B 102B 39.94B 492B 41.32B 40.44B 1,759B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
14/04/26 14,970.58 p -0.12% 110,815
13/04/26 14,988.00 p -1.59% 1,951,201
10/04/26 15,230.00 p -0.30% 2,342,633
09/04/26 15,276.00 p +0.39% 2,694,111
08/04/26 15,216.00 p +1.72% 2,439,972
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
201.63USD
Average target price
220.08USD
Spread / Average Target
+9.15%

Quarterly revenue - Rate of surprise